Logo

CLVT

Clarivate Plc

CLVT

Clarivate Plc • NYSE
$3.76 ▲ 0.27% (+0.01)
Market Cap $2.49 B
52w High $5.88
52w Low $3.04
Dividend Yield 0%
P/E -6.6
Volume 2.32M
Outstanding Shares 661.44M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $623.1M ▲ $360.9M ▼ $-28.3M ▲ -4.542% ▲ $-0.042 ▲ $235.8M ▲
Q2-2025 $621.4M ▲ $410.9M ▲ $-72M ▲ -11.587% ▲ $-0.11 ▲ $197.8M ▲
Q1-2025 $593.7M ▼ $407.5M ▼ $-103.9M ▲ -17.5% ▲ $-0.15 ▲ $164.6M ▲
Q4-2024 $663M ▲ $497.6M ▲ $-191.8M ▼ -28.929% ▼ $-0.27 ▼ $123.7M ▼
Q3-2024 $622.2M $390.4M $-65.6M -10.543% $-0.091 $198.9M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $318.7M ▼ $11.228B ▼ $6.324B ▼ $4.904B ▼
Q2-2025 $362.6M ▲ $11.421B ▼ $6.427B ▼ $4.994B ▼
Q1-2025 $354M ▲ $11.493B ▲ $6.466B ▲ $5.027B ▼
Q4-2024 $295.2M ▼ $11.49B ▼ $6.351B ▼ $5.139B ▼
Q3-2024 $388.5M $12.031B $6.517B $5.513B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-28.3M ▲ $181.1M ▲ $-65.6M ▲ $-154.7M ▼ $-43.9M ▼ $115.5M ▲
Q2-2025 $-72M ▲ $116.3M ▼ $-66M ▼ $-53.9M ▲ $8.6M ▼ $50.3M ▼
Q1-2025 $-103.9M ▲ $171.2M ▲ $-60.9M ▼ $-56.6M ▲ $58.8M ▲ $110.3M ▲
Q4-2024 $-191.8M ▼ $141.3M ▼ $21.4M ▲ $-239.6M ▼ $-93.3M ▼ $59.1M ▼
Q3-2024 $-65.6M $202.9M $-91.5M $-109.7M $12.1M $126.3M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Reoccurring Revenues
Reoccurring Revenues
 $110.00M ▲$110.00M ▲$110.00M ▲$110.00M ▲
Subscription Revenues
Subscription Revenues
 $410.00M ▲$390.00M ▼$410.00M ▲$410.00M ▲
Transaction Revenues
Transaction Revenues
 $140.00M ▲$0 ▼$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has been essentially flat for several years, which suggests limited organic growth and some pressure in parts of the portfolio. The company consistently generates solid gross profit on its sales, showing that the underlying data and software are high‑margin in nature. However, operating profit and net income have been negative for multiple years, with one particularly weak year creating a very large loss. While the size of those losses has narrowed recently, Clarivate is still not consistently profitable, indicating ongoing restructuring, integration costs, or pricing and cost challenges that have yet to be fully resolved.

Balance Sheet

Balance Sheet Clarivate has a sizable asset base built largely on acquired and proprietary data platforms, but total assets and equity have drifted down, reflecting past losses and some balance sheet contraction. The company carries meaningful debt and only a modest cash cushion, which increases financial risk and leaves less room for major missteps. On the positive side, debt has been edging lower over time rather than rising, suggesting some slow but steady deleveraging. Overall, the balance sheet looks serviceable but not especially conservative, and it depends on maintaining healthy cash generation to keep leverage in check.

Cash Flow

Cash Flow Despite recurring accounting losses, Clarivate has produced positive operating cash flow for several years, which is a key strength. Free cash flow after capital spending has also been consistently positive and gradually improving, helped by relatively light investment needs for physical assets. This pattern indicates that the business model can convert a reasonable share of revenue into cash, even while reported earnings are under pressure from non‑cash charges or one‑time items. The main concern is that the cash balance itself is not large relative to debt, so ongoing strong cash generation remains critical.

Competitive Edge

Competitive Edge Clarivate operates in attractive niches—scientific research, life sciences, and intellectual property—where reliable, curated data is mission‑critical for customers. Its well‑known brands and deeply embedded workflow tools create switching costs, especially for universities, life sciences firms, and IP professionals who have built processes around its platforms. The company’s large proprietary datasets and expert curation are difficult and expensive to replicate, which supports a degree of moat. That said, competition from global information powerhouses such as RELX and Elsevier is intense, and some observers question whether Clarivate’s advantages are strong enough to fully protect pricing and growth over the long term.

Innovation and R&D

Innovation and R&D Innovation is a clear strategic focus, particularly around layering artificial intelligence and generative AI on top of Clarivate’s proprietary data. New tools in patents, trademarks, and life sciences search are designed to make complex research and IP analysis faster and more intuitive, often through natural‑language interfaces and automated risk assessments. The company also continues to expand and integrate acquired platforms like ProQuest and MotionHall, aiming to offer end‑to‑end solutions across the research and innovation lifecycle. Key uncertainties are execution risk in integrating acquisitions, the pace of AI adoption by customers, and whether rivals can match or surpass these capabilities with their own AI‑driven offerings.

Summary

Clarivate combines valuable, hard‑to‑replicate data assets with modern analytics and AI, giving it a differentiated position in research, life sciences, and intellectual property workflows. Financially, it shows a mixed picture: strong gross margins and solid cash generation on one side, but flat revenue, persistent accounting losses, and a leveraged balance sheet on the other. The business appears to be slowly improving profitability and reducing debt, yet it has not fully turned the corner to consistent earnings. Future performance will likely hinge on Clarivate’s ability to deepen customer reliance on its platforms, successfully roll out and monetize AI‑enabled products, and manage debt while operating in a highly competitive information services landscape.

NEWS

November 24, 2025 · 3:00 AM UTC

Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI

Read more

November 13, 2025 · 8:15 AM UTC

Clarivate to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 19

Read more

November 12, 2025 · 3:03 AM UTC

Clarivate Announces Highly Cited Researchers 2025 List

Read more

November 6, 2025 · 3:00 AM UTC

Fujifilm Selects IPfolio from Clarivate

Read more

October 30, 2025 · 4:03 AM UTC

Clarivate Pulse of the Library Report Reveals Link Between AI Literacy, AI Implementation and Confidence

Read more